Addressing Global Risk and Opportunities

Response to regulatory uncertainties and rapid innovation in the global supply chains for temperature-controlled medicines were highlighted at the 8th Annual Conference of the Bio Supply Management Alliance (BSMA). Although much attention was naturally placed on large molecule biotech drugs, several speakers made the point that every product has prescribed temperature ranges, even tablets shipped at “ambient temperatures”.   A veteran of the cold chain industry, Douglas Wettergren of Envirotainer remarked,  “This was our seventh year attending the BSMA fall event and this was by far the largest one in terms of delegate attendance.  It is nice to see the interest grow as this is my most valued and favorite industry show of the season.  BSMA sets the bar as the best opportunity to network with executive level decision makers in the Biotech industry.” (more…)

Innovations to Meet Regulatory Requirements, Reduce Costs, and Improve Efficiency

Calabasas, November 12, 2015. The 2015 Bio Supply Management Alliance (BSMA) Conference met in Foster City, CA at the Crowne Plaza Hotel. Executives from over 40 biopharma companies addressed challenges and exchanged solutions for Clinical Supply Chain Management which poses one of the biggest challenges for supply chain managers in the biopharma industry. The fundamental takeaway for the clinical supply professionals was that growth in the number of trials, increased compliance and the global scope of trials, are spurring companies to automate outdated paper-based or spreadsheet based clinical supply chain processes. Based on detailed global surveys of clinical sites, vendors and sponsors have a great deal of improvement to help their sites be more successful. Presenters cited compliance issues – frequent production, protocol, formulation or labeling changes; multiple clinical sites; and, end-to-end clinical supply chain issues stretching all the way to the patient; as the biggest challenges (more…)

Foster City, CA, November 3, 2015:  When the 2015 Bio Supply Management Alliance Conference met in Foster City, CA on October 15th this year, every supply chain professional in attendance was in agreement about one thing. The way that we think about and approach the career path of young professionals in biotech hoping to move up the supply chain management ladder is fundamentally flawed. (more…)

Foster City, CA, October 29, 2015:  The 2015 Bio Supply Management Alliance Conference met in Foster City, CA at the Crowne Plaza Hotel. The 240+ members in attendance heard a broad spectrum of speakers address the major issues confronting supply chain executives in the biopharma industry, namely genomics-data-driven incubation, improved processes in the end-to-end supply chain of this highly regulated industry, and SCM innovations and technologies driving dramatic changes.  The collaboration between BSMA and the Council of Supply Chain Management Professionals (CSCMP) produced a town-hall-like environment at the extraordinary summit of professionals. (more…)

The biopharmaceutical sector is rapidly evolving – can your supply chain keep up?  

By Prashant Yadav, Director of Healthcare Research at the William Davidson Institute, and faculty member of the Ross School of Business at the University of Michigan, USA ~ published in “The Medicine Maker” June 26th, 2015

The biopharmaceutical industry is undergoing a striking transition. In developed markets, one-size-fits-all medicine is being replaced with higher-efficacy treatments for targeted populations. In emerging markets, a burgeoning middle class and larger public investments in healthcare infrastructure are resulting in rapid growth of the pharmaceutical sector. In some developed and emerging markets, reimbursement lists favor domestically produced pharmaceuticals, making local manufacturing a requisite for market entry. Smaller target markets for each molecule; volatility in regulatory and political environment in emerging markets; and stronger payer influence in developed markets are resulting in more frequent changes in commercial decisions. All of these trends are stepping up pressure for speed, flexibility and reliability in the pharmaceutical supply chain. (more…)

In industries such as high-tech electronics and consumer products, the demand-driven supply chain has been a disruptive innovation yielding significantly greater benefits compared with the historical supply driven strategy. In contrast, the biotech industry appears under-served in this regard where a transformation is underway in the industry from being innovators and marketers to becoming a bottom-line focused business. (more…)

A little profit-taking in biotech into year end is only to be expected from Wall Street after such a strong year. Some of the most likely victims for a bit of bloodletting are the strongest winners. Or these companies….[Read More]

THEME: “BIOTECH STRATEGIC SOURCING SUMMIT: REDUCING COST, LEAD TIME & DEFECTS”

Calabasas, CA, March 31, 2014: The world’s leading community of supply chain management professionals in the biopharma industry will come together at Kroc Institute for Peace & Justice at USD on June 24 to focus on the critical issue of Strategic Sourcing in the rapidly globalizing business. The Bio Supply Management Alliance (BSMA) in partnership with the Supply Chain Management Institute (SCMI) of the University of San Diego (USD) will organize the conference to foster the exchange of knowledge, experience and best practices of strategic sourcing from R&D to clinical trials, commercialization, manufacturing and logistics. (more…)

 

Plenary Session in Action

Foster City, CA (PRWEB) October 18, 2013

The convergence of scientific discovery, computing technology, the regulatory framework, and supply chain management intersected at the Bio Supply Management Alliance conference. Industry supply chain leaders gathered to learn the best practices and new approaches to achieve improved operational results.

Devendra Mishra, Executive Director of the Bio Supply Management Conference, opened the just concluded conference by stating, “This industry is obviously driven by scientific discovery, but also by technology advances and supply chain management. As an industry, we are of course subject to extensive governmental regulations.” (more…)

BSMA Launches SCM Initiative for Molecular Diagnostics Testing Industry

Mike Crowell

Mike Crowell

Calabasas, CA, July, 18, 2013: The Bio Supply Management Alliance (BSMA) has appointed Mike Crowell as the Chairman of the “Molecular Diagnostics Testing” strategic steering committee in order to enable sharing of best supply chain management practices, technologies, governmental regulations and market opportunities in a rapidly growing market.

Devendra Mishra, Executive Director of BSMA, stated, “The market for molecular diagnostics is fragmented with more than 500 companies where 98% of them could benefit from being members of a community that shared best practices of supply chain management. (more…)